60 DEGREES PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
60 Degrees Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2022 to Q3 2024.
  • 60 Degrees Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.16M, a 152% decline year-over-year.
  • 60 Degrees Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.91M.
  • 60 Degrees Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.77M, a 39.1% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.91M -$2.16M -$6.34M -152% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$1.57M -$4.17M -$836K -25.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$735K $430K +$3.03M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$3.77M -$2.01M Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $4.18M +$5.63M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$3.34M -$1.19M -55.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 -$1.45M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$2.15M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.